Market Trends of Automated Cell Shaker Industry
The Orbital Shakers Segment is Expected to Witness Significant Growth During the Forecast Period
Orbital shakers are laboratory instruments used to rotate flasks or plates containing cell cultures in a circular motion. There are various types of orbital shakers, namely basic orbital shakers, incubating orbital shakers, CO2 incubating orbital shakers, and stackable orbital shakers. Manufacturers are focusing on the development of orbital shakers due to their high demand in the market. For instance, in March 2023, Thermofisher launched Solaris benchtop temperature-controlled orbital shakers. These shakers come in small and large sizes and offer both incubation and energy-efficient Peltier chillers. The demand for orbital shakers is particularly strong in areas like biopharmaceutical research, drug discovery, stem cell research, and personalized medicine.
Modern orbital shakers are often equipped with a built-in temperature control system, ensuring precise maintenance of optimal growth conditions for different cell lines.
Manufacturers are aiming to reach more customers and expand their market share by focusing on effective distribution channels and strategies. Through this distribution network, manufacturers can effectively reach their target markets in the region. For instance, in May 2023, Eppendorf opened new distribution centers in the United States to improve delivery speed and customer service. The rising distribution network activities by manufacturers are increasing the adoption of automated cell shakers in the market.
Therefore, the orbital shakers segment is expected to witness significant growth over the forecast period due to factors such as demand for modern orbital shakers and manufacturers focusing on product innovations.
North America is Expected to Register a Higher Growth Rate Over the Forecast Period
North America is expected to dominate the market owing to factors such as the region having a robust R&D ecosystem, especially in the fields of biotechnology, pharmaceuticals, and life sciences. For instance, according to PhRMA (Pharmaceutical Research and Manufacturers of America), in September 2022, biopharmaceutical companies in the United States invested USD 101 billion in research and development.
Furthermore, the pharmaceutical and biotechnology industries in North America are among the largest and most advanced globally. For instance, according to the Pharmaceutical Research and Manufacturers of America, in April 2023, biopharmaceutical companies and their suppliers operated 1,580 production facilities across the country in 48 states and Puerto Rico. Additionally, government and private institutions in North America are investing heavily in research infrastructure, including modern laboratories equipped with advanced technologies.
North America is a global hub for life science research, and it requires significant investment. Extensive life science research relies heavily on cell cultures for studies ranging from drug discovery and development to personalized medicine and gene editing. For instance, according to the data published by Invest in Canada, updated in 2024, life science investment was about 2.2 billion USD in Canada for the year 2023. Moreover, the governments in North America are actively investing in the biotechnology research field. This financial support from the government increased funding for laboratory equipment. For instance, according to the fact sheet presented by the White House, in September 2022, the Department of Defense (DOE) planned to invest around USD 178 million in research across biotechnology, bioproducts, and biometrics.
Hence, North America is expected to witness significant market growth during the forecast period due to the increase in R&D activities and the expansion of the pharmaceutical and biotechnology industries.
